FAMBROUGH DOUGLAS
Insider CIK 1259856 · DRNA President and CEO, Director · ONCR Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ONCR Oncorus, Inc. | A Award deriv | 2022-06-22 | 2022-06-24 | 25,000 | — | $0 | 25,000 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | D To issuer deriv | 2021-12-28 | 2021-12-29 | 247,700 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | D To issuer deriv | 2021-12-28 | 2021-12-29 | 250,000 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | D To issuer deriv | 2021-12-28 | 2021-12-29 | 225,000 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | D To issuer deriv | 2021-12-28 | 2021-12-29 | 200,000 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | D To issuer deriv | 2021-12-28 | 2021-12-29 | 200,000 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | D To issuer deriv | 2021-12-28 | 2021-12-29 | 71,900 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | D To issuer deriv | 2021-12-28 | 2021-12-29 | 505,000 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | D To issuer deriv | 2021-12-28 | 2021-12-29 | 255,000 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | D To issuer deriv | 2021-12-28 | 2021-12-29 | 225,000 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | D To issuer deriv | 2021-12-28 | 2021-12-29 | 55,055 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | D To issuer deriv | 2021-12-28 | 2021-12-29 | 281,250 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | D To issuer deriv | 2021-12-28 | 2021-12-29 | 191,330 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | D To issuer deriv | 2021-12-28 | 2021-12-29 | 41,250 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | D To issuer deriv | 2021-12-28 | 2021-12-29 | 59,850 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | D To issuer | 2021-12-28 | 2021-12-29 | 231,431 | $38.25 | $8.85M | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | M Exercise deriv | 2021-12-15 | 2021-12-17 | 13,750 | — | $0 | 41,250 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | F Tax w/h | 2021-12-15 | 2021-12-17 | 5,348 | $38.05 | $203.5K | 231,431 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | M Exercise | 2021-12-15 | 2021-12-17 | 13,750 | — | $0 | 236,779 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | M Exercise deriv | 2021-12-10 | 2021-12-13 | 146,195 | — | $0 | 55,055 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | M Exercise deriv | 2021-12-10 | 2021-12-13 | 33,670 | — | $0 | 191,330 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | M Exercise | 2021-12-10 | 2021-12-13 | 33,670 | $2.97 | $100.0K | 76,834 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | M Exercise | 2021-12-10 | 2021-12-13 | 146,195 | $3.42 | $500.0K | 223,029 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | P Buy | 2021-08-10 | 2021-08-10 | 5,000 | $22.10 | $110.5K | 43,164 | SEC↗ |
| DRNA | A Award deriv | 2021-01-12 | 2021-01-12 | 247,700 | — | $0 | 247,700 | SEC↗ |
| DRNA | A Award deriv | 2021-01-12 | 2021-01-12 | 55,000 | — | $0 | 55,000 | SEC↗ |
| DRNA | M Exercise deriv | 2021-01-08 | 2021-01-12 | 19,950 | — | $0 | 59,850 | SEC↗ |
| DRNA | F Tax w/h | 2021-01-08 | 2021-01-12 | 6,159 | $23.29 | $143.4K | 37,030 | SEC↗ |
| DRNA | M Exercise | 2021-01-08 | 2021-01-12 | 19,950 | — | $0 | 43,189 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | P Buy | 2020-09-01 | 2020-09-01 | 10,000 | $18.06 | $180.6K | 22,300 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | A Award deriv | 2020-01-08 | 2020-01-10 | 79,800 | — | $0 | 79,800 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | A Award deriv | 2020-01-08 | 2020-01-10 | 250,000 | — | $0 | 250,000 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | M Exercise deriv | 2019-12-18 | 2019-12-19 | 80,000 | — | $0 | 201,250 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | M Exercise | 2019-12-18 | 2019-12-19 | 80,000 | $3.42 | $273.6K | 92,300 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | S Sale | 2019-12-18 | 2019-12-19 | 78,569 | $25.85 | $2.03M | 13,731 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | S Sale | 2019-12-18 | 2019-12-19 | 1,431 | $27.07 | $38.7K | 12,300 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | S Sale | 2019-12-17 | 2019-12-19 | 2,305 | $26.94 | $62.1K | 12,300 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | S Sale | 2019-12-17 | 2019-12-19 | 56,716 | $26.13 | $1.48M | 14,605 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | A Award deriv | 2019-01-02 | 2019-01-04 | 505,000 | — | $0 | 505,000 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | A Award deriv | 2018-01-04 | 2018-01-08 | 255,000 | — | $0 | 255,000 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | A Award deriv | 2017-01-03 | 2017-01-05 | 225,000 | — | $0 | 225,000 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | P Buy | 2016-11-15 | 2016-11-16 | 16,500 | $3.63 | $59.9K | 55,579 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | P Buy | 2016-11-14 | 2016-11-16 | 16,600 | $3.78 | $62.7K | 39,079 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | A Award deriv | 2016-01-08 | 2016-01-12 | 225,000 | — | $0 | 225,000 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | A Award deriv | 2015-01-09 | 2015-01-13 | 225,000 | — | $0 | 225,000 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | M Exercise deriv | 2014-12-17 | 2014-12-19 | 1,450 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | M Exercise deriv | 2014-12-17 | 2014-12-19 | 1,050 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | M Exercise | 2014-12-17 | 2014-12-19 | 2,500 | $3.42 | $8.6K | 19,800 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | A Award deriv | 2014-04-16 | 2014-04-18 | 471,900 | — | $0 | 471,900 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | P Buy | 2014-01-29 | 2014-02-20 | 5,000 | $15.00 | $75.0K | 17,300 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | M Exercise deriv | 2013-11-11 | 2014-02-20 | 4,350 | — | $0 | 1,450 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | M Exercise deriv | 2013-11-11 | 2014-02-20 | 4,950 | — | $0 | 1,050 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | M Exercise | 2013-11-11 | 2014-02-20 | 9,300 | $3.42 | $31.8K | 12,300 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | A Award deriv | 2013-09-24 | 2014-02-20 | 281,250 | — | $0 | 281,250 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | A Award deriv | 2013-09-24 | 2014-02-20 | 281,250 | — | $0 | 281,250 | SEC↗ |